← The Wire
NGNENasdaq
Neurogene Inc.
Pharmaceutical Preparations · CIK 1404644
Neurogene Inc. develops genetic medicines for rare neurological diseases using proprietary transgene regulation technology
red 8-K · 90d
$460M
Market cap
$32.28
Last close
+0.8%
1D
+0.1%
5D
545K
Volume
Price · last 39 sessions+14.4%
May 4L $26.14 · H $32.62Jun 29
287
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 29, 20268-KReg FD DisclosureJun 8, 20268-KShareholder VoteJun 4, 20268-KResults of OperationsMay 12, 202610-Q10-QMay 12, 20268-KExecutive Change · Reg FD DisclosureApr 20, 2026DEFA14ADEFA14AApr 16, 2026DEF 14ADEF 14AApr 16, 202610-K10-KMar 24, 20268-KResults of OperationsMar 24, 20268-KReg FD DisclosureFeb 26, 20268-KReg FD DisclosureJan 12, 20268-KResults of OperationsNov 13, 202510-Q10-QNov 13, 20258-KReg FD DisclosureNov 12, 20258-KReg FD DisclosureNov 6, 20258-KReg FD DisclosureOct 9, 2025424B5424B5Aug 11, 20258-KResults of OperationsAug 11, 202510-Q10-QAug 11, 20258-KReg FD DisclosureJun 30, 20258-KExecutive Change · Shareholder VoteJun 12, 20258-KCompany UpdateJun 9, 20258-KResults of OperationsMay 9, 202510-Q10-QMay 9, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KMaterial Agreement · Company UpdateApr 14, 20258-KResults of OperationsMar 24, 202510-K10-KMar 24, 20258-KReg FD DisclosureJan 13, 2025SC 13GSC 13GDec 11, 2024S-1S-1Dec 2, 20248-KReg FD DisclosureNov 21, 202410-Q10-QNov 18, 20248-KResults of OperationsNov 18, 20248-KReg FD DisclosureNov 18, 2024SC 13GNEUROGENE INC.Nov 14, 2024SC 13GSC 13GNov 12, 20248-KReg FD DisclosureNov 12, 2024SC 13GSC 13GNov 8, 20248-KMaterial Agreement · Equity IssuanceNov 4, 202410-Q10-QAug 9, 20248-KResults of OperationsAug 9, 20248-KReg FD DisclosureAug 7, 2024SC 13GSC 13GJul 8, 20248-KReg FD DisclosureJun 21, 20248-KReg FD DisclosureJun 18, 20248-KShareholder VoteJun 17, 20248-KReg FD DisclosureJun 3, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 10, 20248-KReg FD DisclosureMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive ChangeApr 25, 20248-KReg FD DisclosureApr 22, 20248-KExecutive ChangeApr 2, 20248-KResults of OperationsMar 18, 202410-K10-KMar 18, 20248-KReg FD DisclosureMar 4, 20248-KExecutive ChangeFeb 21, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 14, 20248-KReg FD DisclosureJan 5, 2024SC 13GSC 13GDec 27, 2023SC 13DSC 13DDec 21, 20238-KChange of Control · Executive ChangeDec 19, 2023425425Dec 6, 20238-KCompany UpdateDec 6, 2023425425Dec 4, 20238-KCompany UpdateDec 4, 2023425425Nov 30, 202310-Q10-QNov 14, 2023425425Oct 5, 20238-KSecurity-Holder Rights · Bylaw AmendmentSep 22, 2023S-4S-4Aug 21, 202310-Q10-QAug 10, 2023SC 13DSCHEDULE 13DJul 27, 2023
Insider Activity
In the 90 days to Mar 26, 2026: 4 sold $494K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Mcminn RachelChief Executive Officer | Sell | 3,352 | $22.07 | $74K |
| Mar 26, 2026 | Cvijic Christine MikailPresident and CFO | Sell | 2,558 | $21.62 | $55K |
| Mar 26, 2026 | Jordan JulieChief Medical Officer | Sell | 828 | $21.89 | $18K |
| Mar 13, 2026 | Cobb StuartChief Scientific Officer | Sell | 3,991 | $20.41 | $81K |
| Mar 13, 2026 | Cobb StuartChief Scientific Officer | Sell | 2,658 | $21.34 | $57K |
| Mar 13, 2026 | Cvijic Christine MikailPresident and CFO | Sell | 2,387 | $20.42 | $49K |
| Mar 13, 2026 | Cvijic Christine MikailPresident and CFO | Sell | 1,395 | $21.25 | $30K |
| Mar 13, 2026 | Cvijic Christine MikailPresident and CFO | Sell | 263 | $22.02 | $6K |
| Mar 13, 2026 | Cobb StuartChief Scientific Officer | Sell | 148 | $22.08 | $3K |
| Feb 27, 2026 | Cvijic Christine MikailPresident and CFO | Sell | 4,800 | $25.11 | $121K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance